AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation
The causation theory for port catheter failures involves material degradation and biomechanical stresses leading to microfractures, device fracture, and migration. Material breakdown, often involving polymers and possibly accelerated by biomechanical stresses such as flexion, compression, or repeated movement within the body, causes structural failure. These failures result in device migration, embolization, thrombosis, infection, and organ perforation. FDA adverse event reports and expert witness statements suggest that design flaws and inadequate warnings contribute to these failure mechanisms, with long-term material stability and biomechanical stress management being central to preventing such failures.
401
Pending actions
422
Total actions filed
Active
Status
10/03/2024
Established
Who qualifies
Plaintiffs must demonstrate that the port catheter was implanted for a minimum period, often at least 6 months, and that the device experienced failure modes such as fracture, migration, or degradation leading to injuries. The injuries must be linked to device failure, with medical interventions including removal, repair, or treatment of complications like thrombosis or infection. Plaintiffs typically include patients without pre-existing conditions that could confound injury causation, and the failure must not be due to external trauma or misuse.
Products involved
- BioFlo
- Vortex
- SmartPort
- NMI Port
- Port-a-Cath
- PowerPort
- Passport
- Infuse-a-Port
- Medi-Port
- Bardport
- Eco Port
- Clip-a-Port
- Microport
Alleged injuries
- catheter fracture
- device migration
- blood clots
- thrombosis
- infection
- organ perforation
- embolism
This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.